Cargando…

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease

Detalles Bibliográficos
Autores principales: Kim, Jeongah, Park, Inah, Jang, Sangwon, Choi, Mijung, Kim, Doyeon, Sun, Woong, Choe, Youngshik, Choi, Ji-Woong, Moon, Cheil, Park, Sung Ho, Choe, Han Kyoung, Kim, Kyungjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587194/
https://www.ncbi.nlm.nih.gov/pubmed/35499682
http://dx.doi.org/10.1007/s13311-022-01234-7
_version_ 1784813851510833152
author Kim, Jeongah
Park, Inah
Jang, Sangwon
Choi, Mijung
Kim, Doyeon
Sun, Woong
Choe, Youngshik
Choi, Ji-Woong
Moon, Cheil
Park, Sung Ho
Choe, Han Kyoung
Kim, Kyungjin
author_facet Kim, Jeongah
Park, Inah
Jang, Sangwon
Choi, Mijung
Kim, Doyeon
Sun, Woong
Choe, Youngshik
Choi, Ji-Woong
Moon, Cheil
Park, Sung Ho
Choe, Han Kyoung
Kim, Kyungjin
author_sort Kim, Jeongah
collection PubMed
description
format Online
Article
Text
id pubmed-9587194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-95871942022-11-29 Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease Kim, Jeongah Park, Inah Jang, Sangwon Choi, Mijung Kim, Doyeon Sun, Woong Choe, Youngshik Choi, Ji-Woong Moon, Cheil Park, Sung Ho Choe, Han Kyoung Kim, Kyungjin Neurotherapeutics Correction Springer International Publishing 2022-05-02 2022-07 /pmc/articles/PMC9587194/ /pubmed/35499682 http://dx.doi.org/10.1007/s13311-022-01234-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Correction
Kim, Jeongah
Park, Inah
Jang, Sangwon
Choi, Mijung
Kim, Doyeon
Sun, Woong
Choe, Youngshik
Choi, Ji-Woong
Moon, Cheil
Park, Sung Ho
Choe, Han Kyoung
Kim, Kyungjin
Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title_full Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title_fullStr Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title_full_unstemmed Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title_short Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease
title_sort correction to: pharmacological rescue with sr8278, a circadian nuclear receptor rev-erbα antagonist as a therapy for mood disorders in parkinson’s disease
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587194/
https://www.ncbi.nlm.nih.gov/pubmed/35499682
http://dx.doi.org/10.1007/s13311-022-01234-7
work_keys_str_mv AT kimjeongah correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT parkinah correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT jangsangwon correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT choimijung correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT kimdoyeon correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT sunwoong correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT choeyoungshik correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT choijiwoong correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT mooncheil correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT parksungho correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT choehankyoung correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease
AT kimkyungjin correctiontopharmacologicalrescuewithsr8278acircadiannuclearreceptorreverbaantagonistasatherapyformooddisordersinparkinsonsdisease